Ligand Pharmaceuticals reported $64.83M in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acceleron Pharma XLRN:US $ 34.2M 6.26M
Acorda Therapeutics ACOR:US $ 31.46M 0.33M
Agenus AGEN:US $ 252.95M 242.22M
Amgen AMGN:US $ 6706M 180M
Anika Therapeutics ANIK:US $ 39.54M 1.39M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Arrowhead Research ARWR:US $ 38.28M 7.61M
Baxter International BAX:US $ 3226M 128M
Bristol Myers Squibb BMY:US $ 11624M 79M
Clovis Oncology CLVS:US $ 37.92M 1.1M
Dicerna Pharmaceuticals DRNA:US $ 62.95M 21.62M
Eli Lilly And LLY:US $ 6772.8M 32.7M
Enanta Pharmaceuticals ENTA:US $ 23.58M 1.95M
Endo International Ordinary Shares ENDP:US $ 772.03M 58.2M
Flexion Therapeutics FLXN:US $ 21.33M 6.85M
Gilead Sciences GILD:US $ 7421M 1204M
GlaxoSmithKline GSK:LN 9077M 985M
Glaxosmithkline GSK:US $ 9077M 985M
Harsco HSC:US $ 544.3M 25.52M
Heron Therapeutics HRTX:US $ 23.23M 0.79M
Immunogen IMGN:US $ 9.21M 7.74M
Insmed INSM:US $ 46.76M 1.39M
Intrexon XON:US $ 21.56M 12.02M
IONIS PHARMACEUT IONS:US $ 133M 7.25M
Karyopharm Therapeutics KPTI:US $ 37.69M 15.09M
Lannett LCI:US $ 101.52M 4.48M
Ligand Pharmaceuticals LGND:US $ 64.83M 19.84M
Macrogenics MGNX:US $ 15.66M 15.1M
Merk MRK:US $ 13154M 1752M
Pacira Pharmaceuticals PCRX:US $ 127.72M 7.87M
Pfizer PFE:US $ 24094M 5117M
Rigel Pharmaceuticals RIGL:US $ 21.54M 4.72M
Sangamo Biosciences SGMO:US $ 28.56M 0.69M
Teva Pharmaceutical Industries TEVA:US $ 3887M 23M
Veracyte VCYT:US $ 60.37M 5.26M